Pyroptosis in Neurodegenerative disease
DOI:
https://doi.org/10.54097/hset.v36i.5701Keywords:
Pyroptosis, Neurodegenerative disease, Parkinson's disease, Multiple sclerosis, Alzheimer’s disease.Abstract
Neurodegenerative diseases, typically, manifest in the elderly. It is becoming a new epidemic disease over the centuries and causes severe symptom as well as high public cost. Thus, finding the cure of neurodegenerative disease is in urgent need. There has been a lot of interest lately in the neuroinflammation-mediated neuronal death pathway. Aberrant activation of programmed cell death is observed in neurodegenerative disease, leading in undesired loss of neuronal cells and function. Among these, research currently on the pyroptosis, which serves a key function in regulating homeostasis and eliminating unwanted cells, has drawn much attention. Comparing pyroptosis within apoptosis, the unique features of pyroptosis made it possible to be cure of the neurodegenerative disease. Due to its mechanism, it can function differently in different neurodegenerative disease. This review focuses on the characteristics and molecular mechanism of pyrpptosis, in addition, its role in neurodegenerative disease has also been discussed.
Downloads
References
Pearce, N., Ebrahim, S., McKee, M., Lamptey, P., Barreto, M.L., Matheson, D., Walls, H., Foliaki, S., Miranda, J., Chimeddamba, O., Marcos, L.G., Haines, A., Vineis, P. The road to 25x25: how can the five-target strategy reach its goal? [J]. Lancet Glob. Health. 2014, 2: e126–128.
Broe G, CREASEY H. Brain ageing and neurodegenerative diseases: A major public health issue of the Twenty-First century [J]. Perspectives in Human Biology. 1995: 53-58.
Yu, P., Zhang, X., Liu, N. et al. Pyroptosis: mechanisms and diseases [J]. Sig Transduct Target Ther. 2021, 6(1): 128.
Carroll, W.M. The global burden of neurological disorders [J]. Lancet. Neurol. 2019, 18(5): 418-419.
Pearce N, Kromhout H. Neurodegenerative disease: The next occupational disease epidemic? [J]. Occupational and Environmental Medicine. 2014, 71(9):594-595.
Mengli Yue, Li Xiao, Rui Yan, Xinyi Li, Wei Yang. Pyroptosis in neurodegenerative diseases: What lies beneath the tip of the iceberg? [J]. International Reviews of Immunology. 2022:1-16.
L. Vande Walle, M. Lamkanfi. Pyroptosis [J]. Curr. Biol. 2016, 6(13): R568–R572.
Tan, MS., Tan, L., Jiang, T. et al. Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer’s disease [J]. Cell Death Dis 2014, 5: e1382.
Wang, S., Yuan, Y.H., Chen, N.H., Wang, H.B.. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson’s disease. Int. Immunopharmacol. 2019,58–464.
McKenzie, B.A., Mamik, M.K., Saito, L.B., Boghozian, R., Monaco, M.C., Major, E.O., et al. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis [J]. Proc. Natl. Acad. Sci. 2018, 115:6065–E6074
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
